Participation in Forum on February 7, 2021
Rudolf Hein \ Thank you Ruud. Is this part of the review manuscript submitted to Avian Diseases?
Video published on February 27, 2020
Karel Schat (Cornell University) talked about Marek's Disease and Infectious Bursal Disease when discussing this subject, during IPPE 2020 in Atlanta, USA.
Video published on February 20, 2020
Karel Schat (Cornell University) discussed diagnosis, method of vaccination and other recommendations regarding this disease, during IPPE 2020 in Atlanta, USA.
This member gave a presentation on August 8, 2016
At the following event:
2016 AAAP/AVMA Annual Meeting
News published on November 18, 2015
Two Cornell professors emeriti of veterinary medicine have received the 2015 Ezra Technology Innovator Award for their work as co-inventors of the Marek’s disease vaccine. Currently, 22 billion doses of vaccines that treat various strains of Marek’s disease are administered annually to chickens in commercial production, of which Cornell’s vaccine is the most used
On Oct. 22 Prov ...
Video published on July 13, 2015
Dr. Schat talks about the main causes of immunosuppresive diseases and about the strategies to prevent and control immunosuppresive viruses. He also gives his opinon about the evolution of Marek`s disease and the results of the use of the vaccines against chicken anemia virus.
Article published the May 14, 2015
AVIAN DISEASES 58:345–358, 2014Received 16 April 2014; Accepted 1 June 2014; Published ahead of print 1 June 2014
Chickens may be infected with three different oncogenic viruses: avian leukosis virus (ALV), reticuloendotheliosis virus (REV), and Marek’s disease herpesvirus (MDV). Several epidemiological studies have suggested a link between these viruses and differen ...
This member gave a presentation on May 8, 2015
At the following event:
VIII AMEVEA International Seminar 2015
Participation in Forum on August 20, 2014
Both, CAV and limited floor space, can contribute to MD mortality. The latter by causing stress and the former by interfering with immune responses. I am not clear what you meant with"i did CAV vaccine right after 12 day clinical sign of CAV appear after 3week gradually it was diffuse and cause 2.5% mortality",Did you vaccinate at 12 days of age against CAV? And di you then get CAV lesions? if so ...
Article published the August 15, 2014
Although MD is in general well controlled by vaccination in ovo or at one d of age, MD remains a concern for several reasons. First of all, vaccination practices are often suboptimal resulting in some vaccine breaks. Proper use of standard operating procedures at the hatchery remains essential for optimal protection and has been the topic of many presentations. The short-term financi ...